Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis-Reference-Cited by-同舟云学术

Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis

Published:2007-10 Issue:5 Volume:74 Page:446-452
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Sellam Jérémie,Costedoat-Chalumeau Nathalie,Amoura Zahir,Aymard Guy,Choquet Sylvain,Trad Salim,Vignes Bénédicte Lebrun,Hulot Jean-Sébastien,Berenbaum Francis,Lechat Philippe,Cacoub Patrice,Ankri Annick,Mariette Xavier,Leblond Véronique,Piette Jean-Charles

Publisher

Elsevier BV

Subject

Rheumatology

Reference36 articles.

1. A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis;Palladini;Br J Haematol,2001

2. Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation;Palladini;Blood,2004

3. Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis;Gertz;Med Oncol,1999

4. Thalidomide treatment in multiple myeloma;Strasser;Blood Rev,2002

5. Treatment of multiple myeloma;Clerc;Joint Bone Spine,2003

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Cardiac Complications;Cardiac Amyloidosis;2024

2. Drug Interaction Between Favipiravir and Warfarin: A Case Series;Hospital Pharmacy;2023-12-29

3. Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants;Frontiers in Pharmacology;2023-05-19

4. Effectiveness and Safety of Oral Anticoagulants in Cardiac Amyloidosis: Lights and Shadows;Current Problems in Cardiology;2022-03

5. Elevated INR in a COVID‐19 patient after concomitant administration of favipiravir and warfarin: A case report;Journal of Clinical Pharmacy and Therapeutics;2021-08-02